Parallel import of medicinal products: regulatory update
European Pharmaceutical Review
MARCH 14, 2023
This concerns the quantity of the medicinal product in the packaging, ie, the increase or decrease in the number of units of the product in the outer packaging according to local demands and its labelling, including the leaflet, which should be in the language of the country into which the product is imported.
Let's personalize your content